Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,293 total articles
Robert Joseph Deshaies, Chief Operating Officer of Benefits at WEX Inc. (NASDAQ: WEX), has executed a sale of 2,000 shares of the company's common stock on July 6, 2026. The transaction, valued at $296,795, was carried out through a Rule 10b5-1 trading plan adopted earlier in the year. This sale follows a period of significant corporate activity fo…
Egon Durban, a director at Dell Technologies Inc. (NASDAQ:DELL) and Co-CEO of Silver Lake Group, L.L.C., along with affiliated Silver Lake entities, reported the sale of Class C Common Stock valued at approximately $15.18 million on July 6, 2026. The transaction involved the disposition of 33,982 shares, with prices ranging from $405.00 to $419.06 …
Clark Jermoluk Founders Fund I LLC, a significant ten percent shareholder in Ibotta, Inc. (NASDAQ:IBTA), executed a substantial divestment of its holdings in early July 2026. The fund sold 500,000 shares of Ibotta's Class A Common Stock on July 6, 2026, at an average price of $30.15 per share. This transaction resulted in a total realized value of …
Egon Durban, a director at Dell Technologies Inc. (NASDAQ:DELL), alongside affiliated Silver Lake entities, executed sales totaling approximately $29.9 million in Dell Class C Common Stock on July 6, 2026. The transaction involved 72,766 shares priced between $405.36 and $418.49. This sale occurs as Dell's stock has surged 241% over the past year t…
Neil Gregory Almstead, PTC Therapeutics' Chief Technical Operations Officer, executed a series of transactions on July 6 and 7, 2026, selling approximately $4.1 million in common stock while acquiring shares valued at $1.8 million. All activity was conducted under a Rule 10b5-1 trading plan established in November 2025. The trades occurred as the s…
Mark Boulding, Executive Vice President and Chief Legal Officer at PTC Therapeutics, Inc. (NASDAQ: PTCT), executed a series of transactions involving the company's common stock on July 6, 2026. The executive sold 5,079 shares valued at $432,117, while simultaneously acquiring an equivalent number of shares through stock option exercises. These move…
Hershey Trust Co. Trustee in Trust for Milton Hershey School, a significant 10% owner of The Hershey Company (NASDAQ:HSY), executed a series of stock sales totaling 30,000 shares between July 6 and July 8, 2026. The transactions, valued at approximately $5.3 million, were distributed across three consecutive days at varying price points. This insid…
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Chief Financial Officer Eric Bjerkhot executed a series of stock sales on July 6, 2026, totaling $611,273 in value. The transactions, comprising 5,000 shares of common stock, were facilitated through a Rule 10b5-1 trading plan established earlier in the year. This executive divestment takes place against a …
Relay Therapeutics, Inc. (NASDAQ: RLAY) President and CEO Sanjiv Patel executed a sale of 48,199 shares on July 7, 2026, generating $943,736. The transaction, structured under a Rule 10b5-1 plan adopted in October 2025, occurred as the stock approached its 52-week high of $20.20. Prior to the sale, Patel acquired 3,056 shares at $6.95 per share in …
Mirum Pharmaceuticals CEO Christopher Peetz sold 20,000 shares for approximately $2.4 million following the exercise of employee stock options. The transactions, executed under a Rule 10b5-1 plan, occurred as the stock trades near its 52-week high. Peetz retains significant holdings through direct and trust accounts. Recent company developments inc…
Donald A. Bergstrom, President and Chief Scientific Officer at Relay Therapeutics, Inc., completed a sale of 8,660 shares of the company's common stock on July 6, 2026. The transaction, valued at $162,028, was executed under a Rule 10b5-1 trading plan established in late 2025. This divestment occurs against a backdrop of significant price appreciat…
Hartree Partners, LP, a major shareholder in Hudson Technologies Inc. (NASDAQ:HDSN), has increased its position by purchasing an additional $31,351 in common stock. The transactions occurred over two days in early July 2026, bringing Hartree's total holdings to 4,976,536 shares, representing a ten percent ownership stake. This accumulation follows …
Energy Vault Holdings, Inc. (NASDAQ:NRGV) Chief Financial Officer Michael Thomas Beer conducted two significant transactions on July 6, 2026. Beer sold 65,000 shares of common stock valued at $265,200, executed under a Rule 10b5-1 trading plan. The shares were sold at $4.08 per share. On the same day, Beer acquired 50,000 shares through the exercis…
Jon Ayotte, EverQuote's Chief Accounting Officer, executed a series of transactions in early July 2026 under a pre-existing Rule 10b5-1 plan, selling 881 shares while simultaneously exercising options to acquire 3,156 shares. These moves occur against a backdrop of robust Q1 2026 financial performance that beat consensus estimates on both earnings …
David Brainard, Chief Technology Officer at EverQuote, Inc. (NASDAQ:EVER), executed a series of stock sales totaling $126,508 on July 6, 2026. The transactions involved the disposition of 4,960 shares of EverQuote Class A Common Stock, conducted through a Rule 10b5-1 trading plan established in September 2025. This structured approach allows inside…
Joseph Sanborn, EverQuote’s Chief Financial Officer and Chief Administrative Officer, sold 642 shares of the company’s Class A Common Stock on July 6, 2026, totaling $15,729 at a price of $24.50 per share. The transaction was executed under a Rule 10b5-1 trading plan adopted in March 2023 to cover tax withholding obligations from the vesting of res…
Relay Therapeutics CFO Thomas Catinazzo sold 17,717 shares in July 2026 under a pre-established trading plan, netting approximately $331,130. The sale occurred while the stock approached its 52-week high of $20.20, following a significant 450% gain over the past year. Concurrently, the company announced a $275 million stock offering and shared posi…
Jonathan S. Beatty, MD and Head of Advisor Services at Charles Schwab Corp (NYSE:SCHW), executed a sale of 2,000 shares on July 7, 2026, totaling $204,017. The transaction was conducted under a Rule 10b5-1 trading plan adopted earlier in the year, with shares sold at prices between $102.00 and $102.025 per share. This sale occurred as the stock tra…
SenesTech Inc. (NASDAQ: SNES) Chief Executive Officer Michael Edell completed a direct purchase of 1,000 shares on July 7, 2026, bringing his total direct holdings to 5,000 shares. The transaction occurred at $1.4299 per share, totaling $1,429. This acquisition follows a period where SNES shares traded near $1.38, reflecting a 72% decline over the …
Jeremy Allaire, the Chairman and Chief Executive Officer of Circle Internet Group, Inc. (NASDAQ: CRCL), executed a series of transactions involving the sale of Class A Common Stock on July 6, 2026. The total value of the divestment reached $203,619. These sales were conducted in accordance with a pre-arranged 10b5-1 trading plan, a standard mechani…
StandardAero, Inc. (NASDAQ:SARO) CEO Russell Ford executed a series of stock sales totaling $2.42 million in early July 2026 under a pre-established 10b5-1 trading plan. The transactions occurred just before Ford's planned retirement and the appointment of Paul McElhinney as the new Chief Executive Officer. While Ford reduces his stake, analyst opi…
Jeremy Allaire, the Chairman and Chief Executive Officer of Circle Internet Group, Inc., executed a significant divestment of company stock on July 6, 2026. The transactions, conducted under a pre-arranged 10b5-1 trading plan, involved the direct sale of 56,200 Class A Common Stock shares valued at approximately $3,977,894. The sales were executed …
Palo Alto Networks Inc. (NASDAQ:PANW) director Helle Thorning-Schmidt executed a sale of 700 shares on July 7, 2026, totaling $242,795 based on a per-share price of $346.85. Following the transaction, her direct holding stands at 5,898 shares. The sale occurs as the company's stock has appreciated approximately 65% over the past year and 77% over t…
Cory Anne Roclawski, Executive Vice President and Chief Human Resources Officer at Kodiak Gas Services, Inc. (NASDAQ:KGS), executed a sale of company equity on July 8, 2026. The transaction involved the disposal of 4,169 shares at a price of $68.36 per share, totaling $284,992. This sale was conducted under a 10b5-1 trading plan established by Ms. …
Gwendolyn M. Johnson, Senior Vice President of Asset Management at EPR Properties, has executed a transaction to sell 1,000 shares of the company's common stock. The sale, valued at $60,000, was conducted through a trust structure and follows a pre-adopted Rule 10b5-1 trading plan. The transaction occurs as EPR Properties trades near its 52-week hi…
